Chief, Clinical Genetics Service Division of Solid Tumor Oncology Department of Medicine
Memorial Sloan Kettering Cancer Center (MSK) is united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research at the Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research, advancing our understanding of cancer and improving prevention, diagnosis, and treatment. MSK is dedicated to training the next generation of scientists and clinicians.
About the Role
The Division of Solid Tumor Oncology in the Department of Medicine at Memorial Sloan Kettering Cancer Center invites applications for Chief of the Clinical Genetics Service (CGS). This role seeks a visionary leader to advance CGS as a national and international model for hereditary cancer risk assessment, precision prevention, and the integration of cutting-edge science into clinical care.
The Clinical Genetics Service (CGS) is a multidisciplinary team of physicians, genetic counselors, and genetic counselor assistants providing comprehensive hereditary cancer risk assessment and management across MSK’s Manhattan and regional locations. With more than 6,000 outpatient visits annually, CGS is foundational to MSK’s precision prevention and early detection platforms.
The Chief will report to the Division Head of Solid Tumor Oncology (Luis Diaz, MD) and will have strategic, research, clinical, and operational oversight for all aspects of CGS, including defining priorities for clinical excellence, rapid integration of breakthroughs, research portfolio development, talent acquisition, and faculty mentorship.
Responsibilities
- Serve as a catalyst for innovation, setting a bold agenda at the vanguard of cancer genetics and genomic medicine.
- Champion high-impact research and novel clinical approaches that define the future of hereditary cancer risk management and genomics-driven care.
- Drive the translation of scientific advances into direct patient benefit, ensuring MSK remains an epicenter for innovative discovery and implementation.
- Shape a high-performing, collaborative team poised to lead, teach, and mentor in the era of rapidly evolving genetic and genomic technologies.
- Lead close collaborations across MSK’s basic, translational, and population science programs to ensure CGS faculty remain global leaders in advancing precision oncology.
Requirements
- Internationally recognized as an innovator and thought leader in clinical cancer genetics, with a demonstrated commitment to scientific discovery, translational research, and driving the field’s evolution.
- Track record of pioneering and implementing disruptive advances in hereditary cancer syndromes, genomics, or novel precision prevention strategies.
- Demonstrated sustained mentorship, scholarship, and team leadership in clinical, translational, laboratory-based, or population-based science.
About the Team
CGS faculty are at the forefront of clinical cancer genetics, using next-generation sequencing, advanced risk modeling, and state-of-the-art prevention science to benefit patients and their families. The Service delivers personalized recommendations for surveillance, risk reduction, and family assessment, supported by a robust research program spanning cancer genetics, genomic discovery, implementation science, and population health.
Pay
Expected salary range is $335,000–$655,000 for this role (physician compensation based on multiple variables; does not include potential supplemental or one-time performance-based payments at hire).
Benefits
MSK offers a comprehensive benefits package, including competitive compensation, health and retirement benefits, and professional development opportunities. Review our benefits offerings.